Dr. Patrick Boyle is the Head of Codebase at Ginkgo Bioworks, a Boston-based synthetic biology company that makes and sells engineered organisms. Ginkgo’s platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.

The Codebase team leads Ginkgo's customer facing programs and develops the company's "Codebase" portfolio of reusable biological assets. Ginkgo's Codebase includes thousands of novel strains, enzymes, genetic parts and diverse genetic repositories, including millions of engineered DNA sequences.

Patrick was a 2014 fellow in the Johns Hopkins University Center for Health Security's Emerging Leaders in Biosecurity Program, and currently serves on the Board of Life Sciences for the National Academies of Sciences, Engineering and Medicine. Prior to Ginkgo, Boyle received his Ph.D. from Harvard Medical School in 2012, developing synthetic biology applications in bacteria, yeast and plants in the lab of Dr. Pamela Silver. He received a B.S. in biology from the Massachusetts Institute of Technology in 2006.